Leah Abrusci, MS, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 10848 70th Rd, Forest Hills, NY 11375 Phone: 347-292-9051 |
Sirafima Shalomova Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 10470 Queens Blvd Fl 2, Forest Hills, NY 11375 Phone: 718-275-6010 |
Yecika Santos, MS, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 10470 Queens Blvd, Suite 200, Forest Hills, NY 11375 Phone: 718-275-6010 |
Mrs. Sigalit Levi, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 6742 Burns Street, Forest Hills, NY 11375 Phone: 646-354-3826 |
Christina Berdebes, PHD, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 11123 76th Rd Apt C5, Forest Hills, NY 11375 Phone: 305-282-5821 |
Mr. James Michael Baumbusch Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 10470 Queens Blvd, Forest Hills, NY 11375 Phone: 718-275-6010 |
Evienia Irene Vassiliadou Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 10471 Queens Blvd, Forest Hills, NY 11371 Phone: 718-275-6010 Fax: 718-275-6010 |
News Archive
A stunning explosion of zinc fireworks occurs when a human egg is activated by a sperm enzyme, and the size of these "sparks" is a direct measure of the quality of the egg and its ability to develop into an embryo, according to new research from Northwestern Medicine.
It's not unusual for cancer patients being treated with chemotherapy to complain about not being able to think clearly, connect thoughts or concentrate on daily tasks. The complaint - often referred to as chemo-brain - is common. The scientific cause, however, has been difficult to pinpoint.
Genes and cardiovascular health each contribute in an additive way to a person's risk of dementia, U.S. researchers including Sudha Seshadri, MD, and Claudia Satizabal, PhD, of The University of Texas Health Science Center at San Antonio (UT Health San Antonio) reported July 20 in the journal Neurology.
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced preclinical data demonstrating VB-111's potential utility as a targeted cancer treatment.
› Verified 4 days ago